What is the Org number of NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS?

NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS is registered with Brønnøysundsregistrene under Org 865282192.

What is the revenue of NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS?

NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS reported revenue of NOK 11,7M in 2025.

How many employees does NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS have?

NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS employs 1 people as of the latest annual report.

Who is the CEO of NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS?

Helen Merete Olsen is Chief Executive Officer of NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS, in role since 1993.

Who is the chairman of NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS?

Catrine Handelsby chairs the board of NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS, in role since 2024.

Where is NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS headquartered?

NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS's registered address is Lovisenberggata 7C, 0456 Oslo.

NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS

ANSActive

Org 865282192Lovisenberggata 7C, 0456 OsloRetail sale of medical and orthopaedic goods · NACE 4774Est. 19931 employees

Revenue 2025

NOK 11,7M

+27% vs 2024

EBITDA margin

34.8%

+18% vs 2024

Equity ratio

40.8%

Financial strength

Net profit 2025

NOK 4,1M

+18% vs 2024

EBITDA — year on yearNOK millions

Key figuresAnnual report 2025

Revenue	NOK 11,7M	+27%
EBITDA	NOK 4,1M	+18%
Net profit	NOK 4,1M	+18%
Total assets	NOK 5,5M	+77%
Equity	NOK 2,2M	-4%
Employees	1	—

Item	2023	2024	2025
Revenue	7 738	9 238	11 709
Staff expenses	−412	−449	−575
EBITDA	2 660	3 445	4 072
Depreciation & amort.	−8	−23	−33
EBIT	2 652	3 422	4 039
Net financials	1	1	14
Profit before tax	2 653	3 423	4 052
Tax	−0	−0	−0
Net profit	2 653	3 423	4 052

Item	2023	2024	2025
Total assets	4 425	3 093	5 467
Equity	3 816	2 322	2 232
Long-term debt	0	0	0
Short-term debt	609	771	3 235
Total debt	609	771	3 235

Name	Role	Member since
Former (2)
HM Helen Merete Olsen Chief Executive Officer	Chief Executive Officer	1993 – 2024
KH Kristin Haugen Participant With Joint And Several Liability (Fully Responsible)	Participant With Joint And Several Liability (Fully Responsible)	2018 – 2024

Name	Role	Member since
Current (1)
CH Catrine Handelsby	Chairman	2024

Person	Role here	Other companies
Helen Merete Olsen	Chief Executive Officer	0 companies
Kristin Haugen	Participant With Joint And Several Liability (Fully Responsible)	0 companies
Catrine Handelsby	Chairman	0 companies

NORSK LYMFØDEMKLINIKK AVD. KOMPRESJON ANS

ANSActive

Org 865282192Lovisenberggata 7C, 0456 OsloRetail sale of medical and orthopaedic goods · NACE 4774Est. 19931 employees

Revenue 2025

NOK 11,7M

+27% vs 2024

EBITDA margin

34.8%

+18% vs 2024

Equity ratio

40.8%

Financial strength

Net profit 2025

NOK 4,1M

+18% vs 2024

EBITDA — year on yearNOK millions

Key figuresAnnual report 2025

Revenue	NOK 11,7M	+27%
EBITDA	NOK 4,1M	+18%
Net profit	NOK 4,1M	+18%
Total assets	NOK 5,5M	+77%
Equity	NOK 2,2M	-4%
Employees	1	—